TheDiArc Exclusive

Dr Dawson’s – Trust Decay in the American Healthcare Delivery System

Introduction Heart attacks and cancer are the two leading causes...

The Effects Of Cannabis According To Research – TheDiArc.Com

To understand the effects of Cannabis, let us...

Gaurav Pahuja – Singer & Music Composer

Gaurav Pahuja is an Indian Origin Singer and Music...

Clinical Research In US Health Sector – TheDiArc.Com

Medications, gadgets, diagnostic items, and treatment regimens are for human use. Moreover, they are under testing for safety and efficacy in clinical research. The goal is achievable using clinical trials.

The clinical research is compulsory when a nobel medicine or gadget is under testing. To obtain concerns, such as whether it is safe and effective.

Clinical trials are lengthy, meticulous procedures that might take years to complete from beginning to end.

Clinical Trials

The device clinical trials begin in a laboratory and may entail testing the therapy on animals as part of the overall clinical trial process. As soon as a novel therapy seems promising, it is testable on humans in a clinical study.

Clinical Research In Health Sector (US) trials tell us what works and what doesn’t work in the real world. Therefore, they are the finest approach to learning and testing various treatment alternatives for a variety of medical issues.

With A New Health System for the 21st Century (IOM, 2001a), health care quality in the United States is to the fore.

Efforts to build a health care system that assesses and improves the quality of care have increased after the publication of those studies.

A systematic technique to analyze which treatments work and which don’t is essential to such a system. Then, this information is applicable in clinical decision-making. Moreover, this kind of system is a “learning health care system”.

It aims to improve patient outcomes.

According to Christina DiArcabgelo, the policies and practices of a healthcare system are under affect by a wide range of evidence.

Clinical trials, a kind of clinical research, are one of the most credible sources of this information.

Latest

The DiArc Magazine – An Exclusive Lifestyle Magazine| January 2023 | Edition 09 | Christina DiArcangelo

TheDiArc Magazine January 2023 Edition has been published. In this edition we are bringing the best articles as always. We have an Exclusive Interview with Joe Lewis who does decals for vehicles by the name of Royal Customs.

Zelira Therapeutics Completes Enrolment For Diabetic Nerve Pain Drug Trial With Affinity Bio Partners

It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialisation of clinically validated cannabinoid medicines, and Affinity Bio Partners, a leading, global clinical research organisation, have completed enrolment for a diabetic nerve pain drug trial.

CANNABIS – The Revival of an Ancient Women’s Herb With Shabnam

Cannabis - the revival of an ancient women's herb From Egyptian antiquity to the fifteenth century, women relied on a vast knowledge of medicinal plants for their health. Herbal formulations for regulating their fertility, facilitating childbirth, and  intensifying orgasm, to name a few!

Listen to your Gut with Chelsea Haines

My name is Chelsea Haines, I am the founder and CEO of the Gut Health Agency. I have  years of accolades that warrant me credit to share what I’m about to share with you regarding human behaviour and gut health

Newsletter

Don't miss

The DiArc Magazine – An Exclusive Lifestyle Magazine| January 2023 | Edition 09 | Christina DiArcangelo

TheDiArc Magazine January 2023 Edition has been published. In this edition we are bringing the best articles as always. We have an Exclusive Interview with Joe Lewis who does decals for vehicles by the name of Royal Customs.

Zelira Therapeutics Completes Enrolment For Diabetic Nerve Pain Drug Trial With Affinity Bio Partners

It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialisation of clinically validated cannabinoid medicines, and Affinity Bio Partners, a leading, global clinical research organisation, have completed enrolment for a diabetic nerve pain drug trial.

CANNABIS – The Revival of an Ancient Women’s Herb With Shabnam

Cannabis - the revival of an ancient women's herb From Egyptian antiquity to the fifteenth century, women relied on a vast knowledge of medicinal plants for their health. Herbal formulations for regulating their fertility, facilitating childbirth, and  intensifying orgasm, to name a few!

Listen to your Gut with Chelsea Haines

My name is Chelsea Haines, I am the founder and CEO of the Gut Health Agency. I have  years of accolades that warrant me credit to share what I’m about to share with you regarding human behaviour and gut health

How did a stigmatized housewife make it on the NJ Insider 100?

DiAnA was the Community Outreach Specialist for one of the Original 12 license holders a vertically integrated MSO in New Jersey.
Christina DiArcangelo
Christina DiArcangelohttp://www.christinadiarcangelo.com
Christina DiArcangelo has forged a world-class reputation in the Biotechnology and Pharmaceutical industry for the past 22 years. Her engagements have led to numerous industry awards, keynote speaking engagements, TV and media appearances, a multitude of global clinical trials as well as working on several drugs that have received FDA approval and the ultimate respect of her industry peers. Throughout the course of Christina's career, she has acted in various capacities for Global Clinical Research Organizations, Pharmaceutical Companies and Biotechnology Companies.

The DiArc Magazine – An Exclusive Lifestyle Magazine| January 2023 | Edition 09 | Christina DiArcangelo

TheDiArc Magazine January 2023 Edition has been published. In this edition we are bringing the best articles as always. We have an Exclusive Interview with Joe Lewis who does decals for vehicles by the name of Royal Customs.

Zelira Therapeutics Completes Enrolment For Diabetic Nerve Pain Drug Trial With Affinity Bio Partners

It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialisation of clinically validated cannabinoid medicines, and Affinity Bio Partners, a leading, global clinical research organisation, have completed enrolment for a diabetic nerve pain drug trial.

CANNABIS – The Revival of an Ancient Women’s Herb With Shabnam

Cannabis - the revival of an ancient women's herb From Egyptian antiquity to the fifteenth century, women relied on a vast knowledge of medicinal plants for their health. Herbal formulations for regulating their fertility, facilitating childbirth, and  intensifying orgasm, to name a few!